Harrow [HROW] vs Zoetis [ZTS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Harrow Inc. wins in 3 metrics, Zoetis Inc. wins in 17 metrics, with 0 ties. Zoetis Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Harrow Inc. | Zoetis Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -277.07 | 19.58 | Zoetis Inc. |
| Price-to-Book Ratio | 27.78 | 15.04 | Zoetis Inc. |
| Debt-to-Equity Ratio | 483.72 | 279.59 | Zoetis Inc. |
| PEG Ratio | 52.64 | 2.81 | Zoetis Inc. |
| EV/EBITDA | 33.70 | 13.96 | Zoetis Inc. |
| Profit Margin (TTM) | -1.89% | 28.24% | Zoetis Inc. |
| Operating Margin (TTM) | 17.50% | 34.69% | Zoetis Inc. |
| EBITDA Margin (TTM) | 17.50% | 34.69% | Zoetis Inc. |
| Return on Equity | -8.47% | 65.99% | Zoetis Inc. |
| Return on Assets (TTM) | 4.84% | 15.26% | Zoetis Inc. |
| Free Cash Flow (TTM) | $42.76M | $2.28B | Zoetis Inc. |
| Dividend Yield | N/A | 1.21% | N/A |
| 1-Year Return | 24.18% | -51.58% | Harrow Inc. |
| Price-to-Sales Ratio (TTM) | 5.35 | 5.26 | Zoetis Inc. |
| Enterprise Value | $1.65B | $56.75B | Zoetis Inc. |
| EV/Revenue Ratio | 6.04 | 6.00 | Zoetis Inc. |
| Gross Profit Margin (TTM) | 79.27% | 70.17% | Harrow Inc. |
| Revenue per Share (TTM) | $7 | $21 | Zoetis Inc. |
| Earnings per Share (Diluted) | $-0.14 | $6.02 | Zoetis Inc. |
| Beta (Stock Volatility) | 0.31 | 0.97 | Harrow Inc. |
| Short % of Float | 23.20% | 4.06% | Zoetis Inc. |
Harrow Inc. vs Zoetis Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Harrow Inc. | 3.43% | 17.61% | 24.74% | 11.52% | -14.81% | -22.00% |
| Zoetis Inc. | 1.51% | 0.16% | 3.42% | -31.08% | -32.94% | -36.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Harrow Inc. | 24.18% | 101.50% | 351.86% | 903.73% | 572.14% | -68.63% |
| Zoetis Inc. | -51.58% | -53.40% | -57.08% | 71.34% | 156.59% | 156.59% |
Performance & Financial Health Analysis: Harrow Inc. vs Zoetis Inc.
| Metric | HROW | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $1.44B | $49.75B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 492,064 | 2,727,710 |
| 90 Day Avg. Volume | 589,168 | 3,835,940 |
| Last Close | $38.93 | $167.10 |
| 52 Week Range | $28.54 - $54.85 | $139.70 - $200.33 |
| % from 52W High | -29.02% | -16.59% |
| All-Time High | $140.00 (Oct 01, 2007) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -72.19% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.33% | 0.03% |
| Quarterly Earnings Growth | -0.02% | 0.04% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.28% |
| Operating Margin (TTM) | 0.18% | 0.35% |
| Return on Equity (TTM) | -0.08% | 0.66% |
| Debt to Equity (MRQ) | 483.72 | 279.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.41 | $7.84 |
| Cash per Share (MRQ) | $2.02 | $5.48 |
| Operating Cash Flow (TTM) | $43.86M | $2.90B |
| Levered Free Cash Flow (TTM) | $45.18M | $1.79B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.21% |
| Last 12-Month Dividend | N/A | $2.03 |
Valuation & Enterprise Metrics Analysis: Harrow Inc. vs Zoetis Inc.
| Metric | HROW (Apr 24, 2026) | ZTS (Apr 13, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -277.07 | 19.58 |
| Forward P/E | 14.39 | 15.61 |
| PEG Ratio | 52.64 | 2.81 |
| Price to Sales (TTM) | 5.35 | 5.26 |
| Price to Book (MRQ) | 27.78 | 15.04 |
| Market Capitalization | ||
| Market Capitalization | $1.44B | $49.75B |
| Enterprise Value | $1.65B | $56.75B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.04 | 6.00 |
| Enterprise to EBITDA | 33.70 | 13.96 |
| Risk & Other Metrics | ||
| Beta | 0.31 | 0.97 |
| Book Value per Share (MRQ) | $1.41 | $7.84 |
Financial Statements Comparison: Harrow Inc. vs Zoetis Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | HROW (2025) | ZTS (2025) |
|---|---|---|
| Revenue/Sales | 272.30M | 9.47B |
| Cost of Goods Sold | 67.93M | 2.67B |
| COGS % of Revenue | 24.9% | 28.2% |
| Gross Profit | 204.37M | 6.80B |
| Gross Margin | 75.1% | 71.8% |
| Research & Development | 20.94M | 698.00M |
| Operating Income (EBIT) | 30.52M | 3.60B |
| Operating Margin | 11.2% | 38.0% |
| EBITDA | 50.24M | 4.17B |
| EBITDA Margin | 18.4% | 44.1% |
| Pre-Tax Income | -1.37M | 3.36B |
| Pre-Tax Income % of Revenue | -0.5% | 35.5% |
| Income Tax | 3.77M | 687.00M |
| Income Tax % of Revenue | 1.4% | 7.3% |
| Net Income (Profit) | -5.14M | 2.67B |
| Profit Margin | -1.9% | 28.2% |
Balance Sheet & Liquidity Metrics
| Metric | HROW (2025) | ZTS (2025) |
|---|---|---|
| Cash & Equivalents | 72.93M | 2.31B |
| Total Current Assets | 211.75M | 6.77B |
| Total Current Assets % of Revenue | 77.8% | 71.5% |
| Total Current Liabilities | 96.30M | 2.24B |
| Total Current Liabilities % of Revenue | 35.4% | 23.6% |
| Long-Term Debt | 251.09M | 9.24B |
| Long-Term Debt % of Revenue | 92.2% | 97.6% |
| Total Shareholders Equity | 52.09M | 3.33B |
| Retained Earnings | -156.52M | 13.74B |
| Retained Earnings % of Revenue | -57.5% | 145.2% |
| Property, Plant & Equipment | 13.71M | 288.00M |
Cash Flow Statement Comparison
| Metric | HROW (2025) | ZTS (2025) |
|---|---|---|
| Operating Cash Flow | 29.42M | 2.78B |
| Operating Cash Flow % of Revenue | 10.8% | 29.3% |
| Capital Expenditures | -887,000 | N/A |
| Free Cash Flow | 42.76M | 2.28B |
| FCF Margin | 15.7% | 24.1% |
| Debt Repayment | -230.90M | -1.35B |
| Common Stock Repurchase | N/A | -3.24B |
Short Interest & Institutional Ownership Analysis
| Metric | HROW | ZTS |
|---|---|---|
| Shares Short | 6.86M | 15.12M |
| Short Ratio | 6.39 | 3.60 |
| Short % of Float | 23.20% | 4.06% |
| Shares Outstanding | 37.23M | 424.93M |
| Float Shares | 27.35M | 421.29M |
| % Held by Insiders | 16.14% | 0.15% |
| % Held by Institutions | 60.75% | 101.50% |
| % Held by Public | 23.11% | -1.65% |
Dividend Analysis & Yield Comparison: Harrow Inc. vs Zoetis Inc.
| Metric | HROW | ZTS |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.03 |
| Last 12-Month Dividend Yield | N/A | 1.21% |
| 3-Year Avg Annual Dividend | N/A | $1.80 |
| 3-Year Avg Dividend Yield | N/A | 0.29% |
| 3-Year Total Dividends | N/A | $5.39 |
| Ex-Dividend Date | N/A | Jan 20, 2026 |